Cabozantinib for Late Stage Kidney Cancer
Aug 12, 2014 ·
2m 37s
Cometriq (cabozantinib) is already approved for thyroid cancer and is showing promise for late stage kidney cancer.
Information
| Author | cancerGRACE |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
